Merck begins tender offer for Inspire shares, valuing company at $430M
This article was originally published in Scrip
Executive Summary
In line with a deal announced in early April, Merck & Co says that it has commenced the tender offer for all outstanding shares of ophthalmological products company Inspire Pharmaceuticals for $5 per share in cash.